Chronic Paraneoplastic Cutaneous Syndrome Preceding an Indolent Variant of Mantle Cell Lymphoma: Favorable Response to Rituximab

Publisher： Karger

E-ISSN： 1421-9662|115|1-2|113-116

ISSN： 0001-5792

Source： Acta Haematologica, Vol.115, Iss.1-2, 2006-01, pp. : 113-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Another Case of Paraneoplastic Cutaneous Syndrome Preceding Indolent Mantle Cell Lymphoma

By  

Acta Haematologica, Vol. 116, Iss. 3, 2006-10 ,pp. : 228-228

Karger

Access to resources Recommend Favorite

Paraneoplastic Pemphigus Occurs Most Commonly in Indolent B Cell Lymphoma

By  

Acta Haematologica, Vol. 132, Iss. 1, 2014-01 ,pp. : 73-74

Karger

Access to resources Recommend Favorite

Bendamustine plus rituximab for indolent B‐cell lymphoma of renal significance

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 3, 2018-03 ,pp. : 356-362

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combined lenalidomide, low‐dose dexamethasone, and rituximab achieves durable responses in rituximab‐resistant indolent and mantle cell lymphomas

By  

CANCER, Vol. 120, Iss. 2, 2014-01 ,pp. : 222-228

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Synchronous Mantle Cell Lymphoma and Small Lymphocytic Lymphoma with Bendamustine and Rituximab

By  

Acta Haematologica, Vol. 126, Iss. 1, 2011-03 ,pp. : 40-43

Karger

Access to resources Recommend Favorite